Intercept Pharmaceuticals, Inc. is an American biopharmaceutical company incorporated in 2002, focusing on the development of novel synthetic bile acid analogs to treat chronic liver diseases.

Biotechnology

Pharmaceutical

Intercept Pharmaceuticals

Leighland Feinman

Carolin Bevis

Amarita S Randhawa Pharmd

Jared M. Freedberg

Richard Johnson

Elizabeth Perez

Hernan Cortez

Sara Whipple

Doug Houser

Julia Pronina

Thomas Rosenberg

Paul Nitschmann

Ciso Alexandra Zafra Cissp, Cipp, Fip

Theo Altheide

Deryk David

Dick Lancaster

Eve Charles

Linda Richardson

Rocco Venezia

M. Michelle Berrey

Nathan Lai

Jonathan Miles

Valerie Keller

Victoria Carey

Pharm. D. Nikeshia Dunkelly-Allen

Julienne Apacible

Shivam Patel Pharmd, Rph, Mbac

Mustafa Kamal Pharmd

Islah Ahmed

Leona Bessonova Ph.D.

Belen Vendrell

Darren Wheeler

Kryzhanovskaya Ludmila

Xiaomei Jin

Daniel Bajek

Tieng Doan

Evangelia Tsakiraki

Juanita Price

Danielle Andruskiwec

Julie Franklin

Hea-Jin Pons

Sandy Lundy

Medical Affairs and Clinical Operations

Leadership Team

Human Resources and Talent Management

Teams at Intercept Pharmaceuticals

Medical Affairs and Clinical Operations

Leadership Team

Human Resources and Talent Management